These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3031265)

  • 1. [High-performance liquid chromatography of organosulfur compounds using the postcolumn ligand exchange reaction with iodoplatinate. Application to the simultaneous determination of (2R,4R)-2-(o-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidine carboxylic acid (SA446), an angiotensin converting enzyme inhibitor and its urinary metabolites].
    Horiuchi M; Takashina H; Fujimura K; Iso T
    Yakugaku Zasshi; 1986 Nov; 106(11):1028-33. PubMed ID: 3031265
    [No Abstract]   [Full Text] [Related]  

  • 2. A new potent inhibitor of converting enzyme: (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid(SA446).
    Iso T; Yamauchi H; Suda H; Nakata K; Nishimura K; Iwao J
    Jpn J Pharmacol; 1981 Dec; 31(6):875-82. PubMed ID: 6174764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species difference of (2R,4R)-2-(o-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinec arb oxylic acid (SA446) in inhibition of angiotensin converting enzyme.
    Nakata K; Iwatani T; Horiuchi M; Kito H; Yamauchi H; Iso T
    Jpn J Pharmacol; 1986 Mar; 40(3):367-72. PubMed ID: 3012163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined effect of (2R, 4R)-2-(o-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarbo xyl ic acid (SA446) with hydrochlorothiazide or propranolol on development of hypertension in spontaneously hypertensive rats (SHR) by long-term administration].
    Takada T; Nakata K; Yamauchi H; Iso T
    Nihon Yakurigaku Zasshi; 1986 Mar; 87(3):331-7. PubMed ID: 3710315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of angiotensin converting enzyme by (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4- thiazolidinecarboxylic acid, SA 446].
    Horiuchi M; Terashima T; Fujimura K; Shimokawa K; Iso T
    Yakugaku Zasshi; 1984 Dec; 104(12):1257-62. PubMed ID: 6099853
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antihypertensive effects of SA446, hydralazine and the combination on renal hypertensive rats and spontaneously hypertensive rats by long-term treatment].
    Nakata K; Nishimura K; Takada T; Yamauchi H; Iso T
    Nihon Yakurigaku Zasshi; 1986 Feb; 87(2):113-21. PubMed ID: 3699625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of a new antihypertensive agent (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4- thiazolidinecarboxylic acid in blood by high-performance liquid chromatography with electrochemical detection.
    Shimada K; Tanaka M; Nambara T; Imai Y
    J Pharm Sci; 1984 Jan; 73(1):119-21. PubMed ID: 6694067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an angiotensin-converting enzyme (ACE) inhibitor, SA446, on tissue ACE activity in normotensive, spontaneously hypertensive, and renal hypertensive rats.
    Nakata K; Nishimura K; Takada T; Ikuse T; Yamauchi H; Iso T
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):305-10. PubMed ID: 2437397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats.
    Unger T; Yukimura T; Marin-Grez M; Lang RE; Rascher W; Ganten D
    Eur J Pharmacol; 1982 Mar; 78(4):411-20. PubMed ID: 6281036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General pharmacological properties of the potent angiotensin converting enzyme inhibitor rentiapril.
    Yamauchi H; Nishimura K; Nakata K; Suda H; Iso T; Shimizu M; Hiramatsu Y
    Arzneimittelforschung; 1987 Feb; 37(2):157-64. PubMed ID: 3034298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sodium loading on antihypertensive responses to an angiotensin-converting enzyme inhibitor in spontaneously hypertensive and renal hypertensive rats.
    Nakata K; Takada T; Yamauchi H; Iso T
    Eur J Pharmacol; 1986 Feb; 121(2):293-5. PubMed ID: 3009208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive mechanism of an angiotensin converting enzyme inhibitor, SA446, in dogs.
    Nishimura K; Okunishi H; Miyazaki M
    Bull Osaka Med Coll; 1989 Nov; 35(1-2):29-37. PubMed ID: 2486241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antinephritic effect of SA-446, an angiotensin I converting enzyme inhibitor, on crescentic-type anti-GBM nephritis in rats].
    Suzuki Y; Ito M; Yamada H; Saitho N; Tsukushi Y
    Nihon Jinzo Gakkai Shi; 1985 Nov; 27(11):1485-93. PubMed ID: 3007819
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitor of angiotensin I converting enzyme: (4R)-3-[(2S)-3-mercapto-2-methylpropanoyl]-4-thiazolidinecarboxylic acid (YS-980).
    Funae Y; Komori T; Sasaki D; Yamamoto K
    Biochem Pharmacol; 1980 Jun; 29(11):1543-7. PubMed ID: 6249321
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of converting enzyme inhibitors on renin-angiotensin system in normal rats.
    Komori T; Takada T; Funae Y; Yamamoto K
    Osaka City Med J; 1984 Jun; 30(1):17-30. PubMed ID: 6096787
    [No Abstract]   [Full Text] [Related]  

  • 16. Reproductive toxicity studies of rentiapril.
    Cozens DD; Barton SJ; Clark R; Hughes EW; Offer JM; Yamamoto Y
    Arzneimittelforschung; 1987 Feb; 37(2):164-9. PubMed ID: 3034299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of SA-446 in human whole blood and urine by electron capture-gas liquid chromatography.
    Iwatani T; Naitoh M; Takashina H; Nagamori S; Itoh Y; Iwao J
    Chem Pharm Bull (Tokyo); 1982 Jun; 30(6):2087-93. PubMed ID: 6290091
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of YS-980, an orally active converting enzyme inhibitor, on blood pressure in normotensive and hypertensive rats.
    Komori T; Yamamoto K
    Jpn J Pharmacol; 1981 Jun; 31(3):401-7. PubMed ID: 6273629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiative effects of a kinase II inhibitor (Ys980) on carrageenan-induced oedema in rat hind paw and roles of plasma kininogen.
    Suda H; Yamauchi H; Iso T
    J Pharm Pharmacol; 1982 Jan; 34(1):60-1. PubMed ID: 6121038
    [No Abstract]   [Full Text] [Related]  

  • 20. Antihypertensive effects of the novel converting-enzyme inhibitor YS 980 in spontaneously hypertensive rats.
    Unger T; Rockhold RW; Bönner G; Rascher W; Schaz K; Speck G; Schömig A; Ganten D
    Clin Exp Hypertens (1978); 1981; 3(1):121-40. PubMed ID: 6258887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.